Skip to main content
. 2017 Oct 26;143(12):1213–1219. doi: 10.1001/jamaoto.2017.1855

Table 2. Demographic Data of Modified Traditional Cohort and MDC .

Characteristic Traditional Clinic
(n = 50)
Multidisciplinary Clinic
(n = 68)
Difference, %
(95% CI)
Age, mean (SD), y 63.5 (10.2) 60.8 (8.9) 2.7
(−0.8 to 6.2)a
Sex, No. (%)
Male 37 (74) 60 (88) −16
(−31 to −1)
Female 13 (26) 8 (12)
Median distance from clinic (range), kmb 37 (5 to 1520) 54 (3 to 477) −3
(−14 to 10)c
Adult Comorbidity Evaluation-27 scores, No. (%)
None 5 (10) 18 (26) −16
(−29 to −3)
Mild 30 (60) 23 (34) 26
(8 to 44)
Moderate 7 (14) 21 (31) −17
(−32 to −2)
Severe 8 (16) 6 (9) 7
(−5 to 19)
Primary tumor site
Oropharynx 30 (60) 57 (84) −24
(−40 to −8)
Otherd 20 (40) 11 (16)
Tumor stage
1 4 (8) 1 (2) 6
(−2 to 14)
2 3 (6) 3 (4) 2
(−6 to 10)
3 5 (10) 13 (19) −7
(−20 to 6)
4 38 (76) 51 (75) −1
(−17 to 15)
Treatment type
Surgery alone 7 (14) 7 (10) 4
(−8 to 16)
Radiotherapy 0 1 (2) −1
(−4 to 2)
Chemotherapy and radiotherapy 19 (38) 19 (28) 0
(−7 to 27)
Palliative chemotherapy 5 (10) 7 (10) 0
(−11 to 11)
Surgery and adjuvant 13 (26) 29 (43) −17
(−34 to 0)
Neoadjuvant and chemotherapy and radiotherapy 6 (12) 5 (7) 5
(−6 to 16)
a

Mean difference and 95% CI calculated for age.

b

To convert to miles, divide by 1.6.

c

Median difference with 95% CI.

d

Other sites include 9 cases in the hypopharynx, 6 in the supraglottis, 8 in the glottis, 2 in the subglottis, 2 in the sinonasal tract, and 2 with unknown primary tumor sites.